3. Correspondence of six molecular markers between primary tumor (T) and metastatic lymph nodes (N) in evaluable cases of lymph node metastasis.
| Markers | Cases | n (%) | n/N (%)* | ||||
| T(+)N(+) | T(+)N(−) | T(−)N(+) | T(−)N(−) | N(+)/T(+) | |||
| CEA, carcinoembryonic antigen; EpCAM, epithelial cell adhesion molecule; *, the proportion of metastatic lymph nodes positive in the primary tumors positive. | |||||||
| CEA | 47 | 25 (53.2) | 10 (21.3) | 7 (14.9) | 5 (10.6) | 25/35 (71.4) | |
| E-cadherin | 47 | 46 (97.9) | 0 (0) | 0 (0) | 1 (2.1) | 46/46 (100) | |
| EpCAM | 52 | 51 (98.1) | 1 (1.9) | 0 (0) | 0 (0) | 51/52 (98.1) | |
| P-cadherin | 47 | 36 (76.6) | 7 (14.9) | 3 (6.4) | 1 (2.1) | 36/43 (83.7) | |
| CD44v6 | 43 | 0 (0) | 5 (11.6) | 0 (0) | 38 (88.4) | 0/5 (0) | |
| c-erbB2 | 44 | 3 (6.8) | 1 (2.3) | 3 (6.8) | 37 (84.1) | 3/4 (75.0) | |